Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins.
about
Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits.High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays.Autoantibodies against the catalytic domain of BRAF are not specific serum markers for rheumatoid arthritisMucosal and cutaneous human papillomaviruses detected in raw sewagesA novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.Prevalence and risk factors for neutralizing antibodies to human papillomavirus types 16 and 18 in HIV-positive men who have sex with menSerum antibodies to the HPV16 proteome as biomarkers for head and neck cancerRecombinant HPV16 E7 assembled into particles induces an immune response and specific tumour protection administered without adjuvant in an animal modelHPV-E7 delivered by engineered exosomes elicits a protective CD8⁺ T cell-mediated immune responseConstruction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein.Amino-functionalized poly(L-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development.Validation of Serological Antibody Profiles Against Human Papillomavirus Type 16 Antigens as Markers for Early Detection of Cervical Cancer.Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens.Production of functional, stable, unmutated recombinant human papillomavirus E6 oncoprotein: implications for HPV-tumor diagnosis and therapy.The CD8⁺ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIXTM Adjuvant.Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation.A lectin-based diagnostic system using circulating antibodies to detect cervical intraepithelial neoplasia and cervical cancer.Seropositivity of HPV 16 E6 and E7 and the risk of oral cancer.E6/E7 proteins are potential markers for the screening and diagnosis of cervical pre-cancerous lesions and cervical cancer in a Chinese population.Purification and Characterization of Antibodies in Single-Chain Format against the E6 Oncoprotein of Human Papillomavirus Type 16.
P2860
Q33863923-C58F469E-7C45-49C7-9158-94F7C093B2BBQ34037232-02133A52-3109-4365-8488-54FE3C42CAEFQ34103531-C8D94011-64D4-4377-B680-441952FCBD88Q34558258-C7F10F75-9A69-4B44-8E52-00D381C2F533Q34593100-E0DA2B82-B86C-48FD-B6C0-352649C29A39Q34873067-57DEDB9A-B4AD-4C89-B03D-B350CB825F87Q35034741-4FB1DEED-8A07-4BD2-A7EA-F5AF802A954BQ35061200-703B7A39-7C4D-4605-A1EF-B0344CEC45C0Q35232797-1877C162-D8C3-480A-8DC4-FED9383FF194Q35595612-484FA7FD-410C-4769-B6E7-D68BD0D95D55Q35605933-D4492D36-C652-4B63-82C1-FDBED049853AQ36581107-AFA141B5-AC18-4044-AD4E-F11FD54DD3C3Q36775528-B3F6F1C7-28A6-497D-8456-FE28E1D3C449Q37133152-EC3E7D8D-C08E-4E4C-BCDA-5201A550B2BBQ37539231-F523FA46-6E2B-492F-B10E-0E041EAE14E9Q40140715-1AB163EE-D697-46E8-85B0-6DADB5110E19Q41376968-E5FB52AA-BD1C-4D55-8BB6-9F9B043D8784Q42250227-6EAD9646-CFFA-4F02-AD7F-6EF1E42EDEACQ47113153-6075DEC1-A9AB-4FC4-AEAC-5A697F41D14DQ55008093-5F6F2F1A-B3D0-458C-B962-11A5DB111DCE
P2860
Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Serum antibody response to Hum ...... 1, L2, E4, E6 and E7 proteins.
@ast
Serum antibody response to Hum ...... 1, L2, E4, E6 and E7 proteins.
@en
type
label
Serum antibody response to Hum ...... 1, L2, E4, E6 and E7 proteins.
@ast
Serum antibody response to Hum ...... 1, L2, E4, E6 and E7 proteins.
@en
prefLabel
Serum antibody response to Hum ...... 1, L2, E4, E6 and E7 proteins.
@ast
Serum antibody response to Hum ...... 1, L2, E4, E6 and E7 proteins.
@en
P2093
P2860
P356
P1476
Serum antibody response to Hum ...... L1, L2, E4, E6 and E7 proteins
@en
P2093
Alberto Agarossi
Colomba Giorgi
Felicia Grasso
Kari Syrjänen
Luciano Mariani
Marco Ciotti
Margherita Branca
Maria Gabriella Donà
Silvano Costa
Stefania Mochi
P2860
P2888
P356
10.1186/1750-9378-1-6
P577
2006-11-08T00:00:00Z
P5875
P6179
1013688148